Abstract
Glioblastoma (GBM) is the most common primary intracranial malignant tumor in adults. GBM is extremely invasive and aggressive, accounting for the majority of the 200,000 central nervous system (CNS) tumor-related deaths worldwide each year. GBM in children is relatively rare, with distinct molecular characteristics and response to treatment, when compared to adults. The current standard …